Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-11

Clinical Trial Update: Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH [NA]

View source ↗

Summary

A terminated clinical trial comparing the duration of the honeymoon phase in type 1 diabetes among insulin detemir, insulin glargine, and NPH; results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin Glargine (insulin glargine)
  • Insulin detemir (insulin detemir)
  • NPH insulin (insulin isophane)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Type 1 Diabetes | NA | Status: TERMINATED | Results posted: 2019-10-11